As the RNA solutions leader for academic research and therapeutic development, Eclipsebio is dedicated to sponsoring events that bring together world experts in RNA biology and therapeutics. Eclipsebio is proud to announce our sponsorship of the Mechanisms of RNA Decay meeting. The meeting will be held in Lisbon, from August 18 to August 22. This conference will feature discussions on:
- Methods for studying RNA decay
- The process of RNA decay across organisms
- Aspects of RNA decay mechanisms, including the relationship between degradation and translation
We are looking forward to supporting the exciting exchange of ideas and career development opportunities that this meeting offers.
If you are interested in making your own discoveries with our comprehensive solutions for therapeutic development or academic research, contact our team of RNA experts today.
Latest news
Eclipsebio Launches eVERSE™, a First-of-Its-Kind Comprehensive Portfolio of RNA-Focused Datasets for AI Model Success
Eclipse Bioinnovations, Inc. (Eclipsebio), the leading partner for RNA-based and RNA-targeting therapeutic development, today announced the launch of its eVERSE™ portfolio of AI-ready datasets. eVERSE is a first-in-class collection of datasets generated from all key aspects of RNA biology that inform therapeutic development from target discovery to drug design.
2025 Data Catalyst Award Announcement
To support researchers as they generate RNA datasets, Eclipsebio is proud to announce the 2025 Data Catalyst Award. Winners of the award will obtain matching funds to cover the cost of generating their control datasets.
Decoding Microproteins Across Evolution and Disease
Eclipsebio is proud to announce their sponsorship of the 2025 Gordon Research Conference on Decoding Microproteins Across Evolution and Disease in Barcelona.
Eclipsebio Expands eMERGE™ Platform with eSENSE dsRNA™ for dsRNA Quantification and Localization
SAN DIEGO, September 3, 2024 — Eclipse Bioinnovations, Inc. (Eclipsebio), the leader in developing precision solutions for RNA-based and RNA-targeting therapeutics, today announced the launch of its eSENSE dsRNA™ assay. eSENSE dsRNA is a next-generation sequencing method for the robust quantification, localization, and optimization of double-stranded RNA (dsRNA) contaminants in RNA-based vaccines and therapeutics. “By […]